Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism

Journal of Endocrinological Investigation

Volumn 22, Issue 3, 1999, Pages 165-168

  Müderris, Iptisam Ipek ^a   Bayram, F ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Flutamide therapy; Hirsutism

Indexed keywords

ANDROSTENEDIONE; FLUTAMIDE; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; THYROID HORMONE;

ADOLESCENT; ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; THYROID HORMONE BLOOD LEVEL;

EID: 0345561562     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343536     Document Type: Article

References (16)

1. Krischner MA, Bardin C.W. Androgen production and metabolism in normal and virilized women. Metabolism 21: 667, 1972.
2. Biffignandi P., Massuchetti C., Molinatti G.M. Female hirsutism: Pathophysiological considerations and therapeutic implications. Endocr. Rev. 5: 498, 1984.
3. Tremblay R.R. Treatment of hirsutism with spironolactone. J. Clin. Endocrinol. Metab. 5: 363, 1986.
4. Belisle L., Love E.J. Clinical efficacy and safety of cyproterone acetate in severe hirsutism: Results of a multicentered Canadian study. Fertil. Steril. 46: 1015, 1986.
5. Dodin S., Faure N., Cedrin I., Mechain C., Turcot-Lemay L., Guy J., Lemay A. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. Clin. Endocrinol. (Oxf.) 43: 575, 1995.
6. Neri R., Kassem N. Biological and clinical properties of antiandrogens. Progress in Cancer Research and Therapy 37: 507, 1984.
7. Moghetti P., Castello R., Negri C., Tosi F., Magnani C.M., Fontanarosa M.C., Armanini D., Muggeo M. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior. Fertil. Steril. 64: 511, 1995.
8. Cesur V., Kamel N., Uysal A.Z., Erdǒgan G., Başkal N. The use of antiandrogen flutamide in the treatment of hirsutism. Endocr. J. 41: 573, 1994.
9. Marcondes J.A.M., Minnani S.L., Luthold W.W., Bernardo L.W., Samojlik E., Kirschner M.A. Treatment of hirsutism in women with flutamide. Fertil. Steril. 57: 543, 1992.
10. Müderris I.I., Bayram F., Şahin Y., Keleştimur F., Tutuş A., Ayata D. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism. Fertil. Steril. 66: 220, 1996.
11. Hatch R., Rosenfield R., Kim M.H., Tredway D. Hirsutism: implications, etiology, and managment. Am. J. Obstet Gynecol. 140: 815, 1981.
12. Falsetti L., De Fusco D., Eleftheriou G., Rosina B. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary sydrome. Gynecol. Endocrinol. 11: 251, 1997.
13. Erenus M., Gürbüz O., Durmuşoǧlu F., Demirçay Z., Pekin S. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertil. Steril. 61: 613, 1994.
14. Cusan L., Dupont A., Gomez J.-L., Tremblay R.R., Labrie F. Comparison of flutamide and spironolactone in the treatment of hirsutism: A randomized controlled trial. Fertil. Steril. 61: 28, 1994.
15. Moller S., Iversen P., Franzmann M.B. Flutamide-induced liver failure. J. Hepatol. 10: 346, 1990.
16. Wysdwski D.K., Freiman J.P., Tourtelot J.B., Horton M.L. Fatal and nonfatal hepatotoxicity associated with flutamide. Ann. Intern. Med. 118: 860, 1993.